Open AccessWhat factors are associated with a woman's decision to take hormone replacement therapy? Evaluated in the context of a decision aid
Author(s) -
Clark Heather D.,
O'Connor Annette M.,
Graham Ian D.,
Wells George A.
Publication year - 2003
Publication title -
health expectations
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.314
H-Index - 74
eISSN - 1369-7625
pISSN - 1369-6513
DOI - 10.1046/j.1369-6513.2003.00216.x
Subject(s) - context (archaeology) , hormone replacement therapy (female to male) , hormone therapy , psychology , medicine , computer science , geography , testosterone (patch) , cancer , archaeology , breast cancer
Abstract Objectives To understand the factors associated with a post‐menopausal woman deciding to take hormone replacement therapy (HRT) after reviewing a decision aid (DA) and having a counselling visit with her physician as well as the factors associated with the act of taking HRT 2 months after the counselling interview. Design A secondary analysis of data collected for a randomized controlled trial evaluating two DAs. Main outcome results Although 28% of women were uncertain regarding their decision after the counselling interview, only 2.4% of women, at the assessment at 2 months, had not made a decision. The most significant factor associated with the decision to take HRT, after the physician visit, was the physician preference (OR: 62, 95% CI: 13.3, 289.7). Physician preference (OR: 78, 95% CI: 6.2, 975) remained the most significant factor for taking HRT 2 months after the counselling interview followed by low uncertainty about the decision (OR: 0.4, 95% CI: 0.2, 0.7). Conclusion Physician preference was the factor that was most associated with the woman's decision following counselling and 2 months later. Qualitative evaluation of the interview process involving the patient and physician would determine whether the patient and physician are reaching a shared decision or is the physician preference influencing the patient.